293 related articles for article (PubMed ID: 7967107)
21. [Combination therapy with 5-FU, etoposide and CDDP (FEP regimen) in advanced primary and recurrent gastric cancer].
Namatame K; Sasaki E; Koh Y; Shimada K; Nakamura T; Hirose T; Ookubo M; Nakayoshi A
Gan To Kagaku Ryoho; 1992 May; 19(5):625-30. PubMed ID: 1580637
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and toxicity of lower dose UFT without leucovorin in metastatic gastric cancer patients.
Somali I; Meydan N; Tarhan MO; Oztop I; Alacacioglu A; Yilmaz U
J BUON; 2009; 14(3):429-33. PubMed ID: 19810134
[TBL] [Abstract][Full Text] [Related]
23. [PMUE therapy (CDDP, MMC, UFT, etoposide) for advanced gastric cancer--a case report].
Matsumoto H; Yonemura Y; Kosaka T; Muraoka K; Kaji M; Nakai M; Tsugawa K; Segawa M; Fushida S; Takano Y
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2227-30. PubMed ID: 1444489
[TBL] [Abstract][Full Text] [Related]
24. [A case of gastric cancer with multiple liver metastases showing marked efficacy of preoperative and postoperative chemotherapy with CDDP, MMC and UFT(PMU), or CDDP, MMC, UFT and etoposide (PMUE)].
Kinoshita K; Kato M; Sawa T; Yoshimitsu S; Tomita F; Takano Y; Yonemura Y; Miyazaki I; Matsui H
Gan To Kagaku Ryoho; 1993 Apr; 20(5):651-5. PubMed ID: 8470925
[TBL] [Abstract][Full Text] [Related]
25. Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer.
Sanchiz F; Milla A
Jpn J Clin Oncol; 1994 Dec; 24(6):322-6. PubMed ID: 7830337
[TBL] [Abstract][Full Text] [Related]
26. [A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy].
Ueda N; Yoshimitsu Y; Ohta N; Kadoya N; Hirosawa H; Konishi I; Izumi R; Hirono T; Saito K
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1833-6. PubMed ID: 8937494
[TBL] [Abstract][Full Text] [Related]
27. [Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
Sakata Y; Chiba Y; Sato T; Kimura M; Fukushi G; Matsukawa M; Wada K; Aoyama H; Sawada Y; Fukushi M
Gan To Kagaku Ryoho; 1992 Feb; 19(2):195-201. PubMed ID: 1736831
[TBL] [Abstract][Full Text] [Related]
28. [TS-1/CDDP therapy for advanced gastric cancer as neoadjuvant chemotherapy].
Nakamura M; Maruyama K; Furukawa J; Maruyama N; Tanaka J; Katsumoto Y; Yokouchi H; Nakaguchi K; Sue F; Yoshihara W
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1823-8. PubMed ID: 12402437
[TBL] [Abstract][Full Text] [Related]
29. Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients.
Yonemura Y; Kinoshita K; Fujimura T; Fushida S; Sawa T; Matsuki N; Tanaka S; Kamata T; Takashima T; Miyazaki I
Hepatogastroenterology; 1996; 43(11):1260-72. PubMed ID: 8908561
[TBL] [Abstract][Full Text] [Related]
30. [UFT/CDDP treatment in advanced gastric cancer--case report].
Suga S; Nagai H; Horiuchi Y; Ohkita T; Ibayashi J; Koyama Y
Gan No Rinsho; 1989 Jan; 35(1):87-92. PubMed ID: 2493527
[TBL] [Abstract][Full Text] [Related]
31. [Combination chemotherapy of UFT with adriamycin in advanced gastrointestinal cancer].
Koda K; Kure T; Terada S; Arai R; Morita K; Hirayama M; Terui T; Fukushi A; Yoshizaki N; Nakazawa O
Gan No Rinsho; 1987 Sep; 33(11):1329-35. PubMed ID: 3118075
[TBL] [Abstract][Full Text] [Related]
32. [Combined UFTM for 140 patients with advanced gastric cancer].
Jin ML
Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):130-2. PubMed ID: 2553364
[TBL] [Abstract][Full Text] [Related]
33. [Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP].
Ohwada S; Miyamoto Y; Takeshita M; Fujii T; Uchida O; Tanahasi Y; Aoyagi H; Izuo M
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3487-9. PubMed ID: 2802641
[No Abstract] [Full Text] [Related]
34. Neoadjuvant chemotherapy of gastric cancer with oral UFT (a mixture of uracil and fturafur) during the waiting period for surgery.
Nio Y; Sato Y; Nagami H; Teramoto M; Inoue Y; Yano S; Sumi S; Tamura K; Fukumoto M
Anticancer Res; 1998; 18(1B):523-30. PubMed ID: 9568172
[TBL] [Abstract][Full Text] [Related]
35. [Successful UFT-E granule and 5-FUCDDP combination therapy for an unresectable advanced gastric cancer complicated with liver metastasis].
Kushibiki K; Shimada M; Matsuoka H; Hyakuna Y; Yokomichi H
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1313-5. PubMed ID: 8831744
[TBL] [Abstract][Full Text] [Related]
36. [A case of unresectable advanced gastric cancer with peritoneal dissemination responding to UET/low-dose CDDP combination chemotherapy].
Baba M; Higaki N; Nishihara M; Ishida M; Kawasaki H; Sasayama Y
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2541-4. PubMed ID: 12506479
[TBL] [Abstract][Full Text] [Related]
37. The role of additional chemotherapy with oral UFT in intravenous combination chemotherapy with cisplatin and 5-fluorouracil for human gastric cancer xenograft lines of well- and poorly- differentiated adenocarcinomas transplanted in nude mice.
Tseng CC; Nio Y; Tsubono M; Kawabata K; Masai Y; Hayashi H; Fukumoto M; Tobe T
Anticancer Res; 1992; 12(4):1295-9. PubMed ID: 1503424
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of the combination of chemotherapy with etoposide, adriamycin and cisplatin (EAP) in advanced or recurrent gastric cancer].
Terata N; Sano H; Ishibashi H; Tani T; Hanasawa K; Endo Y; Kurumi Y; Shibata J; Kodama M; Tsuji K
Gan To Kagaku Ryoho; 1993 Apr; 20(5):611-6. PubMed ID: 8470918
[TBL] [Abstract][Full Text] [Related]
39. [Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
Arima S; Yamamoto H; Hisatsugu T; Ohkuma R; Ohsato K; Abe R; Nakamura Y; Fukuyama N; Yamanouchi A; Taira A
Gan To Kagaku Ryoho; 1991 Mar; 18(3):443-9. PubMed ID: 1900685
[TBL] [Abstract][Full Text] [Related]
40. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
